FDA-Drug2013-03-13Class II
ABILIFY (aripiprazole) Tablets, 30 mg, Rx only, Blister Pack of 100 tablets, Otsuka America Pharmaceutical Inc., Bristol-Myers Squibb NDC 59148-011-35
Bristol Myers Squibb Manufacturing Company
Hazard
CGMP Deviations: A drum of Abilify 30 mg Tablets rejected during the compression stage was not segregated from the other portion of the lot and was inadvertently shipped, packaged and distributed.
Sold states
LA, TN, CA
Affected count
21 blister packs
Manufactured in
Rd #3 Km 77.5, N/A, Humacao, PR, United States
Products
ABILIFY (aripiprazole) Tablets, 30 mg, Rx only, Blister Pack of 100 tablets, Otsuka America Pharmaceutical Inc., Bristol-Myers Squibb NDC 59148-011-35
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-181-2013Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief